1. Home
  2. DXCM vs TPL Comparison

DXCM vs TPL Comparison

Compare DXCM & TPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • TPL
  • Stock Information
  • Founded
  • DXCM 1999
  • TPL 1888
  • Country
  • DXCM United States
  • TPL United States
  • Employees
  • DXCM N/A
  • TPL N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • TPL Oil & Gas Production
  • Sector
  • DXCM Health Care
  • TPL Energy
  • Exchange
  • DXCM Nasdaq
  • TPL Nasdaq
  • Market Cap
  • DXCM 34.1B
  • TPL 29.1B
  • IPO Year
  • DXCM 2005
  • TPL N/A
  • Fundamental
  • Price
  • DXCM $85.80
  • TPL $1,113.01
  • Analyst Decision
  • DXCM Strong Buy
  • TPL Strong Buy
  • Analyst Count
  • DXCM 19
  • TPL 1
  • Target Price
  • DXCM $98.32
  • TPL $917.00
  • AVG Volume (30 Days)
  • DXCM 4.0M
  • TPL 127.3K
  • Earning Date
  • DXCM 07-24-2025
  • TPL 05-07-2025
  • Dividend Yield
  • DXCM N/A
  • TPL 0.57%
  • EPS Growth
  • DXCM N/A
  • TPL 6.27
  • EPS
  • DXCM 1.33
  • TPL 19.99
  • Revenue
  • DXCM $4,148,000,000.00
  • TPL $727,664,000.00
  • Revenue This Year
  • DXCM $16.66
  • TPL $19.48
  • Revenue Next Year
  • DXCM $15.35
  • TPL $19.76
  • P/E Ratio
  • DXCM $64.41
  • TPL $55.73
  • Revenue Growth
  • DXCM 9.11
  • TPL 10.36
  • 52 Week Low
  • DXCM $57.52
  • TPL $578.56
  • 52 Week High
  • DXCM $127.61
  • TPL $1,769.14
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 61.53
  • TPL 28.87
  • Support Level
  • DXCM $84.51
  • TPL $1,349.71
  • Resistance Level
  • DXCM $87.67
  • TPL $1,300.00
  • Average True Range (ATR)
  • DXCM 2.06
  • TPL 50.16
  • MACD
  • DXCM -0.42
  • TPL -27.76
  • Stochastic Oscillator
  • DXCM 55.37
  • TPL 1.42

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About TPL Texas Pacific Land Corporation

Texas Pacific Land Corp is mainly engaged in the sales and leases of land owned, retaining oil and gas royalties, and the overall management of the land owned. It operates its business in two reportable segments; Land and Resource Management and Water Service and Operations. The Land and Resource Management segment focuses on managing surface acres of land and its oil and gas royalty interests, principally concentrated in the Permian Basin. The Water Services and Operations segment encompasses the business of providing full-service water offerings to operators, produced-water treatment, infrastructure development, and disposal solutions. The company generates the majority of its revenue from the Land and Resource Management segment.

Share on Social Networks: